Imatron CEO Lewis Meyer said his company’s sale of an electron-beam tomography scanner to The Matilda Hospital in Hong Kong not only helps the company’s finances but also may be a harbinger of an upswing in activity in the Asia-Pacific
Imatron CEO Lewis Meyer said his companys sale of an electron-beam tomography scanner to The Matilda Hospital in Hong Kong not only helps the companys finances but also may be a harbinger of an upswing in activity in the Asia-Pacific regions capital equipment market.
The Matilda Hospital will use the EBT scanner for coronary artery scanning, electron-beam angiography, and lung scanning. South San Francisco, CA-based Imatron has placed 29 EBT scanners in Japan and five in China. This is the sixth EBT scanner Imatron has sold in its second quarter of 2000.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Key MRI Findings Predictive of Treatment Response for Unresectable Hepatocellular Carcinoma
July 14th 2025For patients with unresectable hepatocellular carcinoma, a pre-treatment MRI finding of LI-RADS tumor in vein was associated with over an 86 percent lower likelihood of responding to transcatheter arterial chemoembolization (TACE) and targeted immunotherapy.